East Midlands Academic Health Science Network – igniting innovation Dr Carl EdwardsPresentation Transcript
East Midlands AcademicHealth Science Network –Igniting InnovationDr Carl Edwards, Interim Industry Lead | East Midlands AHSN
East Midlands Academic Health Science Network“Igniting Innovation”Who are EMAHSN?2Dr Carl EdwardsInterim Industry Lead, EMAHSN
3• Introduced in “Innovation Health and Wealth” December 2011• Comprehensive NHS, University and Industry collaboration“Improving the identification, adoption and spread of innovativehealthcare”• To serve population of 3-5 million• Comprehensive coverage: 15 nationally, 5 year licence• AHSN Guidance issued 20th June 2012• Expression of Interest submission 20th July 2012• Submission of Prospectus 1st October 2012• Interview 3rd December 2012• Feedback 20th May 2013What is an Academic Health Science Network[AHSN]?
4• Six key functions and levers:• Promoting participation in research• Translating research and learning into practice• Collaborating on education and training• Driving service improvement• Ensuring information is at the core of AHSN work• Wealth creation• Must also address:• NHS Outcomes Framework; NHS Midlands and East clusterambition[s]; “Sunset Review”; Six High Impact Innovations;NICE guidance; specific suite of industry requirementsWhat are the AHSNs intended to do?
5Academic Health Science Networks (AHSNs)
Former miningarea with highlevels ofdeprivationand healthinequalitiesLarge,dispersedrural areaLargemigrantworkforceHigh levels ofavoidable mortalityegsmoking, alcohol, self harmHighest rate of hipfractures inEnglandLeicesterforecast to beBritain’s first‘majorityminorityethnic’ city by2012ZerodeprivationTop 10% lifeexpectancyCorby has lowestlife expectancy inthe region (bottom5%)Significant migrantworkforceEMAHSN Geography – where are we?Multi-ethnic, diverse, metropolitanpopulations in Leicester, Nottingham andDerbyStark difference in deprivation, and lifeexpectancy between the city and county6
EMAHSN vision and values - what do we stand for?7
EMAHSN operational delivery How will we work?8
EMAHSN and the New NHS Architecture – February 20139
10East Midlands Academic Health Science Network“Igniting Innovation”Why does EMAHSN Engage with Industry?
11NHS and its relationship with IndustryAHSNs first proposed in “Innovation, Health and Wealth”, the NHS is key toenabling and sustaining economic growth.“The NHS contributes significantly to the UK economy in four important ways:• through the services it provides, a healthy population is more productive,and more economically active• by adopting innovation to improve its own productivity, it can deliver morehealth benefit for a given public resource• by accelerating adoption and diffusion of innovation, it supports growth inthe health-related industry, helping to create new jobs• by exporting innovation, ideas and expertise, in partnership with UKindustry.”
1212EMAHSN Engaging with Industry“It works at the limits of science – bringing the highest levels of humanknowledge and skill to save lives and improve health.”EMAHSN core values in building relationships with industry:1. Improving patient outcomes and experience will be the basis of allrelationships2. Collaborations supported by EMAHSN will address our clinical themes anddeliver benefits that can be applied to the whole East Midlands3. There will be mutual benefits for both industry and the NHS in working incollaboration4. There will be equitable contribution to collaborations in time andresources5. The process and outcomes of collaborations will be transparent to NHS,industry and the public
13East Midlands Academic Health Science Network“Igniting Innovation”How does EMAHSN Engage with Industry?
14EMAHSN operational delivery How will we work?
15Key stages to engage with Industry“... build alliances across internal and external networks and actively sharelatest best practice and provide for rapid evaluation and adoption...”“Stepping Stones”
16Transparency – Industry Advisory Panel16Role Potential source(s)Chair EMAHSN Industry Board MemberPharmaceutical Industry e.g. Association of British Pharmaceutical IndustriesBiotechnology Industry e.g. BioIndustry Association, One NucleusTechnology Industry e.g. Association of British Healthcare Industries,Medilink, British In Vitro Diagnostics AssociationInvestor Community e.g. East Midlands Business Angels, regional fundsLocal Economic Development Local Enterprise Partnerships, Chamber of CommerceNational Trade Organisation UK Trade and Investment, Technology Strategy Board,Department of Business Innovation and SkillsNHS representative NHS R&D Director, or Head of the Clinical ResearchNetworkNHS training representative Director of Innovation, East Midlands Local Educationand Training BoardHEI Representative Head of Enterprise OfficePatient and Carer representative EMAHSN Public, and Patient Involvement group
171717Emerging theme – Experimental MedicineEast Midlands strength in drug development and formulation.• Early EMAHSN engagement highlighted key industrial needs• Lack of awareness of capabilities in NHS and academia• ”Igniting Innovation” themed event 4th March 2013• 56 attendees• NOCRI, Biomedical Research Units, NHS Biobanks, Industry• “Increasing Research participation”, “Improving DiversePopulations needs”
18Emerging theme – Partnership WorkingTransformation of health outcomes and the reduction ofunwarranted variation requires system wide changes to carepathways.• EMAHSN membership of the ABPI RIG• Early engagement with communications strategy• Clinical needs prioritisation• “Improving Diverse Populations needs”, “Understanding andsupporting the Translation process”• NICE TA support
19Expanding engagementAdding value, not duplicating effort
20East Midlands Academic Health Science Network“Igniting Innovation”What has industry asked from EMAHSN?
21Feedback from consultationsSimplify, do not become another layer to penetrate!“The difficulty is trying to simplify the myriad processes; one advantage you bringis being a simple “front end” so that Industry see you first”• Better visibility of the assistance available• Higher profile for NIHR Networks and the current timelines• Help to promote UK to international pharma• Assistance to start research and evaluations in the NHS/NIHRManaged access to NHS and academia, consistent and predictable
How can EMAHSN work best with industry?Simplify, do not become another layer to penetrate!• Alignment with research engagement with industry• Additive activities that support the NIHR• New Partnership Working models• Opportunities to ‘cross sell’• New research questions• Unmet clinical needs• Robust evaluations
23Contact detailsProfessor Rachel Munton, Interim Managing DirectorRachel.firstname.lastname@example.org 0115 82 31300 I 07825 656341Margaret Woolley, Head of Programme OfficeMargaret.Woolley@nhs.net , 07899 964957Carl Edwards, Interim Industry LeadCarl.email@example.com 0115 74 84256Email: firstname.lastname@example.orgWebsite: www.emahsn.ac.ukTelephone: 0115 82 31298Twitter: @EM_AHSN